-
R333445-1mgRobinetinidin chloride.
-
R418555-100mgROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.
-
R418555-25mgROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.
-
R418555-500mgROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.
-
R418555-5mgROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.
-
R422274-1mlROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.
-
R335072-100mgRolitetracycline.
-
R335072-1gRolitetracycline.
-
R335072-25mgRolitetracycline.
-
R335072-5mgRolitetracycline.
-
-
R114337-10mgRonidazole-d3.